GLYAT and COVID-19: Two of these, the aminoglycoside phosphotransferase APH(2’’)-IIa, and the aminoglycoside acetyltransferase AAC(6’)-Ie-APH(2’’), were more abundant in COVID-19 patients compared to CTRLs (Figure 5A).